Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis

  1. Alexander M Walter  Is a corresponding author
  2. Rainer Müller
  3. Bassam Tawfik
  4. Keimpe DB Wierda
  5. Paulo S Pinheiro
  6. André Nadler
  7. Anthony W McCarthy
  8. Iwona Ziomkiewicz
  9. Martin Kruse
  10. Gregor Reither
  11. Jens Rettig
  12. Martin Lehmann
  13. Volker Haucke
  14. Bertil Hille
  15. Carsten Schultz
  16. Jakob Balslev Sorensen  Is a corresponding author
  1. University of Copenhagen, Denmark
  2. European Molecular Biology Laboratory (EMBL), Germany
  3. Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany
  4. University of Washington School of Medicine, United States
  5. Saarland University, Germany

Abstract

Phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] is essential for exocytosis. Classical ways of manipulating PI(4,5)P2 levels are slower than metabolism, making it difficult to distinguish effects of PI(4,5)P2 from those of its metabolites. We developed a membrane-permeant, photoactivatable PI(4,5)P2, which is loaded into cells in an inactive form and activated by light, allowing sub-second increases in PI(4,5)P2 levels. By combining this compound with electrophysiological measurements in mouse adrenal chromaffin cells, we show that PI(4,5)P2 uncaging potentiates exocytosis and identify synaptotagmin-1 (the Ca2+ sensor for exocytosis) and Munc13-2 (a vesicle priming protein) as the relevant effector proteins. PI(4,5)P2 activation of exocytosis did not depend on the PI(4,5)P2-binding CAPS-proteins, suggesting that PI(4,5)P2 uncaging bypasses CAPS-function. Finally, PI(4,5)P2 uncaging triggered the rapid fusion of a subset of readily-releasable vesicles, revealing a rapid role of PI(4,5)P2 in fusion triggering. Thus, optical uncaging of signaling lipids can uncover their rapid effects on cellular processes and identify lipid effectors.

Article and author information

Author details

  1. Alexander M Walter

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    awalter@fmp-berlin.de
    Competing interests
    No competing interests declared.
  2. Rainer Müller

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3464-494X
  3. Bassam Tawfik

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1193-8494
  4. Keimpe DB Wierda

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8784-9490
  5. Paulo S Pinheiro

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    No competing interests declared.
  6. André Nadler

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  7. Anthony W McCarthy

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  8. Iwona Ziomkiewicz

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    Iwona Ziomkiewicz, Performed experiments as an employee of University of Copenhagen and is now an employee of AstraZeneca; IZ has no financial investments in AstraZeneca.
  9. Martin Kruse

    Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, United States
    Competing interests
    No competing interests declared.
  10. Gregor Reither

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  11. Jens Rettig

    Center for Integrative Physiology and Molecular Medicine, Saarland University, Homburg, Germany
    Competing interests
    No competing interests declared.
  12. Martin Lehmann

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  13. Volker Haucke

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
    Competing interests
    No competing interests declared.
  14. Bertil Hille

    Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, United States
    Competing interests
    No competing interests declared.
  15. Carsten Schultz

    Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Competing interests
    No competing interests declared.
  16. Jakob Balslev Sorensen

    Center for Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    For correspondence
    jakobbs@sund.ku.dk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5465-3769

Funding

European Union 7th Framework programme (HEALTH-F2-2009-242167)

  • Jakob Balslev Sorensen

The independent Research Fond Denmark

  • Jakob Balslev Sorensen

The Novo Nordisk Foundation

  • Jakob Balslev Sorensen

The Lundbeck Foundation

  • Paulo S Pinheiro
  • Jakob Balslev Sorensen

European Molecular Biology Laboratory

  • Carsten Schultz

Deutsche Forschungsgemeinschaft (Transregio83)

  • Alexander M Walter
  • Carsten Schultz

Deutsche Forschungsgemeinschaft (Emmy Noether Programme)

  • Alexander M Walter

National Institutes of Health (R37NS008174)

  • Bertil Hille

Alexander von Humboldt-Stiftung

  • Martin Kruse

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Permission to keep and breed knockout mice for this study was obtained from The Danish Animal Experiments Inspectorate (2006/562−43, 2012−15−2935−00001). The animals were maintained in an AAALAC-accredited stable in accordance with institutional guidelines as overseen by the Institutional Animal Care and Use Committee (IACUC).

Copyright

© 2017, Walter et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,818
    views
  • 847
    downloads
  • 45
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexander M Walter
  2. Rainer Müller
  3. Bassam Tawfik
  4. Keimpe DB Wierda
  5. Paulo S Pinheiro
  6. André Nadler
  7. Anthony W McCarthy
  8. Iwona Ziomkiewicz
  9. Martin Kruse
  10. Gregor Reither
  11. Jens Rettig
  12. Martin Lehmann
  13. Volker Haucke
  14. Bertil Hille
  15. Carsten Schultz
  16. Jakob Balslev Sorensen
(2017)
Phosphatidylinositol 4,5-bisphosphate optical uncaging potentiates exocytosis
eLife 6:e30203.
https://doi.org/10.7554/eLife.30203

Share this article

https://doi.org/10.7554/eLife.30203

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.

    1. Cell Biology
    Weihua Wang, Junqiao Xing ... Zhangfeng Hu
    Research Article

    Existence of cilia in the last eukaryotic common ancestor raises a fundamental question in biology: how the transcriptional regulation of ciliogenesis has evolved? One conceptual answer to this question is by an ancient transcription factor regulating ciliary gene expression in both uni- and multicellular organisms, but examples of such transcription factors in eukaryotes are lacking. Previously, we showed that an ancient transcription factor X chromosome-associated protein 5 (Xap5) is required for flagellar assembly in Chlamydomonas. Here, we show that Xap5 and Xap5-like (Xap5l) are two conserved pairs of antagonistic transcription regulators that control ciliary transcriptional programs during spermatogenesis. Male mice lacking either Xap5 or Xap5l display infertility, as a result of meiotic prophase arrest and sperm flagella malformation, respectively. Mechanistically, Xap5 positively regulates the ciliary gene expression by activating the key regulators including Foxj1 and Rfx families during the early stage of spermatogenesis. In contrast, Xap5l negatively regulates the expression of ciliary genes via repressing these ciliary transcription factors during the spermiogenesis stage. Our results provide new insights into the mechanisms by which temporal and spatial transcription regulators are coordinated to control ciliary transcriptional programs during spermatogenesis.